Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Helicobacter Pylori Breath Test for Children Approved

By LabMedica International staff writers
Posted on 06 Mar 2012
A breath test for children aged 3 to 17 can detect Helicobacter pylori bacterial infections.

The urea breath test (UBT) method is more convenient compared with invasive H. More...
pylori tests. It is accurate and noninvasive. No blood, stool, or biopsy is needed—patients avoid the potential risks and discomforts associated with more invasive testing methods.

The test is based on the ability of H. pylori to break down urea into carbon dioxide, which is then absorbed from the stomach and eliminated in the breath. For the test, patients swallow a capsule containing urea made from an isotope of carbon. If H. pylori are present in the stomach, the urea is broken up and turned into carbon dioxide. The carbon dioxide is absorbed across the lining of the stomach and into the blood. It then travels in the blood to the lungs where it is excreted in the breath. Samples of exhaled breath are collected, and the isotopic carbon in the exhaled carbon dioxide is measured.

The BreathTek UBT test for H.pylori is manufactured by Otsuka America Pharmaceutical (Rockville, MD, USA). It was approved by the US Food and Drug Administration (FDA; Silver Spring, MD, USA) for adults in 1996. The first breath test for use in children was approved by the FDA on February 22, 2012.

The FDA based its approval of the BreathTek UBT test for children on a multicenter study of 176 patients, comparing its performance to a composite reference method and demonstrating 95.8 % sensitivity and 99.2 % specificity. An additional study was done at 1 to 6 months after therapy to support use for post-treatment monitoring of patients. The sensitivity was 83.3 % and the specificity was 100%.

The American College of Gastroenterology considers the urea breath test (UBT) to be the most reliable nonendoscopic method for discovering H.pylori infections. By assessing the entire gastric mucosa, BreathTek UBT avoids the sampling errors seen in biopsy methods.

H. pylori infections cause chronic stomach inflammation (gastritis) and ulcers. Most people with this infection do not have any symptoms but have a two- to six-fold increased risk of developing gastric cancer and mucosal-associated-lymphoid-type lymphoma compared with uninfected people.

“Results from this test, when considered with a physician’s assessment of the patient’s history, other risk factors, and professional guidelines, can quickly indicate infection, which allows a physician to initiate appropriate health measures in a timely manner,” said Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostic device evaluation and safety in FDA’s Center for Devices and Radiological Health.

Related Links:

Otsuka America Pharmaceutical
US Food and Drug Administration
The American College of Gastroenterology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.